Since over 50% of human breast cancer cells express binding sites (receptors) for luteinizing hormone releasing hormone (LHRH), LHRH is one of the specific targeting receptors that can be used for the treatment of breast cancer38–40. The gene discussed is GNRH1; the disease is breast carcinoma.